In the first quarter of 2021, P&G's revenue reached $114.9 billion, a year-on-year increase of 2.6%.

Pfizer reported a first quarter revenue of $11.49 billion, a 2.6% increase year-on-year from the estimated $10.86 billion. Adjusted earnings per share for the first quarter were $1.58, compared to $1.80 in the same period last year, and an estimated $1.40. Pfizer still predicts a full-year adjusted gross margin of approximately 69% to 70%. The company also forecasts full-year revenue of about $46 billion to $47.5 billion, and adjusted earnings per share of $6.05 to $6.35.